{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:50:29Z","timestamp":1790740229576,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Timely and adequate management are the key priorities in the care of peritonitis. This review focuses on the cornerstones of the medical support: source control and antiinfective therapies<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Peritonitis from community-acquired or healthcare-associated origins remains a frequent cause of admission to the ICU. Each minute counts for initiating the proper management. Late diagnosis and delayed medical care are associated to dramatically increased mortality rates. The diagnosis of peritonitis can be difficult in these ICU cases. The signs of organ failures are more relevant than biological surrogates. A delayed source control and a late anti-infective therapy are of critical importance. The quality of source control and medical management are other key elements of the prognosis. The conventional rules applied for sepsis are applicable for peritonitis, including hemodynamic support and anti-infective therapy. Growing proportions of multidrug resistant pathogens are reported from surgical samples, mainly related to Gram-negative bacteria. The increasing complexity in the care of these critically ill patients is a strong incentive for a multidisciplinary approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Early clinical diagnosis, timely and adequate source control and antiinfective therapy are the essential pillars of the management of peritonitis in ICU patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000805","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T23:17:21Z","timestamp":1609456641000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Priorities in peritonitis"],"prefix":"10.1097","volume":"27","author":[{"given":"Philippe","family":"Montravers","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Paris, UFR Denis Diderot"},{"name":"INSERM UMR 1152"},{"name":"Anesthesiology and Critical Care Medicine, Bichat-Claude Bernard University Hospital, Pole PARABOL, AP-HP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksud","family":"Assadi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, UFR Denis Diderot"},{"name":"Anesthesiology and Critical Care Medicine, Bichat-Claude Bernard University Hospital, Pole PARABOL, AP-HP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Gouel-Cheron","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, UFR Denis Diderot"},{"name":"Anesthesiology and Critical Care Medicine, Bichat-Claude Bernard University Hospital, Pole PARABOL, AP-HP"},{"name":"Antibody in Therapy and Pathology, Pasteur Institute, UMR 1222 INSERM, Paris, France"},{"name":"Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-019-05819-3","article-title":"Epidemiology of intra-abdominal infection and sepsis in critically ill patients: \u2018AbSeS\u2019, a multinational observational cohort study and ESICM Trials Group Project","volume":"45","author":"Blot","year":"2019","journal-title":"Intensive Care Med"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13017-017-0145-2","article-title":"The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship-results from an international cross-sectional survey","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00134-019-05841-5","article-title":"Postoperative abdominal infections: epidemiology, operational definitions, and outcomes","volume":"46","author":"Bassetti","year":"2020","journal-title":"Intensive Care Med"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1749-7922-9-37","article-title":"Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study","volume":"9","author":"Sartelli","year":"2014","journal-title":"World J Emerg Surg"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1007\/s00268-018-4687-6","article-title":"Postoperative peritonitis after digestive tract surgery: surgical management and risk factors for morbidity and mortality, a cohort of 191 patients","volume":"42","author":"Bensignor","year":"2018","journal-title":"World J Surg"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13017-019-0253-2","article-title":"Physiological parameters for prognosis in abdominal sepsis (PIPAS) Study: a WSES observational study","volume":"14","author":"Sartelli","year":"2019","journal-title":"World J Emerg Surg"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcrc.2019.02.029","article-title":"Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection","volume":"52","author":"van de Groep","year":"2019","journal-title":"J Crit Care"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bjs5.50269","article-title":"Anastomotic leakage after elective colorectal surgery: a prospective multicentre observational study on use of the Dutch leakage score, serum procalcitonin and serum C-reactive protein for diagnosis","volume":"4","year":"2020","journal-title":"BJS Open"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00365521.2015.1066422","article-title":"Association between surgical delay and survival in high-risk emergency abdominal surgery. A population-based Danish cohort study","volume":"51","author":"Vester-Andersen","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/cc13854","article-title":"Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock","volume":"18","author":"Azuhata","year":"2014","journal-title":"Crit Care"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00268-019-05254-x","article-title":"Delay in source control in perforated peptic ulcer leads to 6% increased risk of death per hour: a nationwide cohort study","volume":"44","author":"Boyd-Carson","year":"2020","journal-title":"World J Surg"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00268-017-4233-y","article-title":"Early versus delayed source control in open abdomen management for severe intra-abdominal infections: a retrospective analysis on 111 cases","volume":"42","author":"Rausei","year":"2018","journal-title":"World J Surg"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/cid\/cit128","article-title":"Source control review in clinical trials of antiinfective agents in complicated intra-abdominal infections","volume":"56","author":"Solomkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/sur.2014.166","article-title":"Inadequate source control and inappropriate antibiotics are key determinants of mortality in patients with intra-abdominal sepsis and associated bacteremia","volume":"16","author":"Tellor","year":"2015","journal-title":"Surg Infect (Larchmt)"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10096-016-2775-9","article-title":"Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multicentric analysis comparing intensive care versus surgical wards in Spain","volume":"36","author":"Lagunes","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcrc.2018.12.001","article-title":"Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients","volume":"50","author":"De Pascale","year":"2019","journal-title":"J Crit Care"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13017-017-0132-7","article-title":"Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00268-018-4871-8","article-title":"Early laparoscopic washout may resolve persistent intra-abdominal infection postappendicectomy","volume":"43","author":"Allaway","year":"2019","journal-title":"World J Surg"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","article-title":"Effect of a multifaceted educational intervention for antiinfectious measures on sepsis mortality: a cluster randomized trial","volume":"43","author":"Bloos","year":"2017","journal-title":"Intensive Care Med"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/ciy768","article-title":"Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and the risk of surgical site infection after colorectal surgery: a prospective cohort study","volume":"68","author":"Dubinsky-Pertzov","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13756-020-00733-6","article-title":"Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors","volume":"9","author":"Voor In \u2019t Holt","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"ofz504","DOI":"10.1093\/ofid\/ofz504","article-title":"Carbapenem treatment and outcomes among patients with culture-positive complicated intra-abdominal infections in US hospitals: a retrospective cohort study","volume":"6","author":"Zilberberg","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciz089","article-title":"The Infectious Diseases Society of America's 10\u200a\u00d7\u200a\u201920 initiative (10 new systemic antibacterial agents US Food and Drug Administration approved by 2020): Is 20\u200a\u00d7\u200a\u201920 a possibility?","volume":"69","author":"Talbot","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"ofaa104","DOI":"10.1093\/ofid\/ofaa104","article-title":"What's hot in clinical infectious diseases? 2019 IDWeek Summary","volume":"7","author":"Moss","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13756-019-0652-x","article-title":"Cost-effectiveness analysis comparing ceftazidime\/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane\/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)","volume":"8","author":"Kongnakorn","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"e02313","DOI":"10.1128\/AAC.02313-19","article-title":"Meropenem-vaborbactam versus ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae Infections","volume":"64","author":"Ackley","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/cid\/ciz530","article-title":"RESTORE-IMI 1: A multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem\/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections","volume":"70","author":"Motsch","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"e02203","DOI":"10.1128\/AAC.02203-19","article-title":"Comparison of treatment outcomes between analysis populations in the RESTORE-IMI 1 phase 3 trial of imipenem-cilastatin-relebactam versus colistin plus imipenem-cilastatin in patients with imipenem-nonsusceptible bacterial infections","volume":"64","author":"Kaye","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"ofz344","DOI":"10.1093\/ofid\/ofz344","article-title":"Estimating the treatment of carbapenem-resistant Enterobacteriaceae infections in the United States using antibiotic prescription data","volume":"6","author":"Clancy","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2217\/fmb-2019-0135","article-title":"Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance","volume":"14","author":"Solomkin","year":"2019","journal-title":"Future Microbiol"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamasurg.2016.4237","article-title":"Assessing the efficacy and safety of eravacycline vs ertapenem in complicated intra-abdominal infections in the Investigating Gram-Negative Infections Treated with Eravacycline (IGNITE 1) trial: a randomized clinical trial","volume":"152","author":"Solomkin","year":"2017","journal-title":"JAMA Surg"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/cid\/ciy1029","article-title":"IGNITE4: Results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs meropenem in the treatment of complicated intraabdominal infections","volume":"69","author":"Solomkin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit Care"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cmi.2016.10.001","article-title":"Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units","volume":"23","author":"Montravers","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","article-title":"A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients","volume":"45","author":"Martin-Loeches","year":"2019","journal-title":"Intensive Care Med"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10096-019-03617-9","article-title":"Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies","volume":"38","author":"Sganga","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13054-016-1267-8","article-title":"Characteristics and outcomes of antiinfective de-escalation during healthcare-associated intra-abdominal infections","volume":"20","author":"Montravers","year":"2016","journal-title":"Crit Care"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jac\/dkz407","article-title":"Serum and peritoneal exudate concentrations after high doses of \u03b2-lactams in critically ill patients with severe intra-abdominal infections: an observational prospective study","volume":"75","author":"Leon","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00134-018-5088-x","article-title":"Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial","volume":"44","author":"Montravers","year":"2018","journal-title":"Intensive Care Med"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:12:56Z","timestamp":1753819976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000805","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,30]]}}}